We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Bionest Partners and Scisive Consulting Merge

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Success in today’s competitively evolved medical industry requires insightful strategy informed by operating practicalities. Bionest Partners has combined with Scisive Consulting to create a new model consulting firm intensely responsive to, and highly qualified for, the planning needs of a new generation of medical business leaders and investors. This fusion of two highly-respected medical business consultancies equips us to deal with the new demands of the medical marketplace, and also enables each to augment its intellectual capital and expand its geographic coverage.

Bionest Partners’ new senior management team will be Alain J. Gilbert and Bob J. Easton, as Co-Chair, together with partners Dr. Mary Koto, Catharine Staughton, Olivier Lesueur and Dr. Sean Hu, offering:

•    Complementarity of leadership, at once Strategic with Bob J. Easton and Operational with Alain J. Gilbert, to guarantee our clients "Practical Operability" of our recommendations
•    Broader sector and deeper functional expertise: drugs/devices/diagnostics (including personalized medicine); research/development/marketing/planning/pricing/corporate development
•    Personalized Medicine Strategy, widely recognized consulting expertise
•    Geographic reach, with offices in Paris, London, New York, San Diego and affiliates in Munich and Tokyo